financetom
Business
financetom
/
Business
/
Macy's Likely to Withdraw Fiscal Guide Amid Tariff, Macro Uncertainty, UBS Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Macy's Likely to Withdraw Fiscal Guide Amid Tariff, Macro Uncertainty, UBS Says
May 26, 2025 6:11 AM

03:12 PM EDT, 05/12/2025 (MT Newswires) -- Macy's (M) is likely to withdraw its fiscal 2025 guidance when it reports fiscal Q1 results, due to tariff and macro uncertainties, UBS Securities said in a note Monday.

The firm said its channel checks suggest Q1 sales trends were slightly better than expected, and it forecasts earnings of $0.15 per share, a cent above the Street consensus.

"Thus, we don't expect [Macy's] 1Q report to lead to significant revisions of the Street's estimates or move the stock's P/E much," the firm said.

UBS said the options market was pricing a plus-minus 3.4% change in the stock's price following Macy's Q1 earnings release versus a 7.5% historical average move.

"We see a wide range of potential outcomes," UBS said.

Separately, Washington and Beijing reached an agreement on a 90-day suspension of reciprocal duties following their talks in Switzerland over the weekend. The two sides had been in a trade war since President Donald Trump's announcement of sweeping new tariffs early last month.

US Treasury Secretary Scott Bessent said Monday he expects to meet with Chinese officials again "in the next few weeks" to continue trade negotiations, CNBC reported.

UBS has a sell rating on the stock with a price target of $6.

Macy's stock was up nearly 6% in recent Monday trading.

Price: 12.29, Change: +0.67, Percent Change: +5.77

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise
Syros Gets Fast Track Label For Tamibarotene to Treat Acute Myeloid Leukemia; Shares Rise
Apr 9, 2024
11:02 AM EDT, 04/09/2024 (MT Newswires) -- Syros Pharmaceuticals ( SYRS ) said Tuesday it has received the fast track designation from the US Food and Drug Administration for tamibarotene plus azacitidine and venetoclax to treat acute myeloid leukemia with RARA overexpression in people over 75 years or with comorbidities that preclude the use of intensive induction chemotherapy. Tamibarotene is...
Boeing deliveries drop by half in March due to increased quality checks
Boeing deliveries drop by half in March due to increased quality checks
Apr 9, 2024
April 9 (Reuters) - Boeing ( BA ) said on Tuesday it had delivered 29 airplanes in March, down more than half from the 64 delivered in the same month a year ago, as 737 MAX production slipped on increased quality checks and audits by regulators. Boeing ( BA ) has said it is producing fewer MAX single-aisle jets to...
National Bank of Canada Says Calibre's Q1 Production In Line With Forecast
National Bank of Canada Says Calibre's Q1 Production In Line With Forecast
Apr 9, 2024
11:02 AM EDT, 04/09/2024 (MT Newswires) -- National Bank of Canada said Tuesday that Calibre Mining Corp.'s ( CXBMF ) first-quarter production of 61,800 ounces aligned with the bank's forecast of 63,300 ounces. The bank said Calibre's production is weighted to the second half as expected per the company's guidance, with additional organic high-grade mineralization teed up, including potential contributions...
Looking At Shopify's Recent Unusual Options Activity
Looking At Shopify's Recent Unusual Options Activity
Apr 9, 2024
Deep-pocketed investors have adopted a bearish approach towards Shopify ( SHOP ) , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in SHOP usually suggests something big is about to happen. We gleaned this information from...
Copyright 2023-2026 - www.financetom.com All Rights Reserved